Skip to main content
Top
Published in: BMC Gastroenterology 1/2010

Open Access 01-12-2010 | Research article

Prevalence of Helicobacter pyloriinfection among new outpatients with dyspepsia in Kuwait

Authors: Waleed M Alazmi, Iqbal Siddique, Nabeel Alateeqi, Basil Al-Nakib

Published in: BMC Gastroenterology | Issue 1/2010

Login to get access

Abstract

Background

Testing and treatment for Helicobacter pylori has become widely accepted as the approach of choice for patients with chronic dyspepsia but no alarming features. We evaluated H. pylori status among outpatients with uninvestigated dyspepsia in Kuwait.

Methods

A prospectively collected database for 1035 patients who had undergone 13C-urea breath tests (UBT) for various indications was reviewed for the period from October 2007 to July 2009. The status of H. pylori in dyspeptic patients was determined by UBT.

Results

Among the 362 patients who had undergone UBT for uninvestigated dyspepsia, 49.7% were positive for H. pylori (95% CI = 44%-55%) and the percentage increased with age (35.8% at 20-29 years, 95% CI = 25.4% - 47.2%; 59.3% at 30-39 years, 95% CI = 48.5% - 69.5%) (P = 0.013). The prevalence of H. pylori was 42.6% among Kuwaitis (95% CI = 35%-50%) and 57.6% (95% CI = 49.8%-65%) among expatriates (p = 0.004). The prevalence among males was 51.3%, while in females it was 48.6%.

Conclusions

Almost half of the patients with dyspeptic symptoms in Kuwait were positive for H. pylori, though the prevalence varied with age and was higher among expatriates. The American Gastroenterology Association guidelines recommending testing and treatment for H. pylori for patients with uninvestigated dyspepsia should be endorsed in Kuwait.
Appendix
Available only for authorised users
Literature
1.
go back to reference Go MF: Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002, 16 (Suppl): 3-15. 10.1046/j.1365-2036.2002.0160s1003.x.CrossRefPubMed Go MF: Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002, 16 (Suppl): 3-15. 10.1046/j.1365-2036.2002.0160s1003.x.CrossRefPubMed
2.
go back to reference Rosenstock S, Kay L, Rosenstock C, Andersen L, Bonnevie O, Jørgensen T: Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut. 1997, 41 (2): 169-76.CrossRefPubMedPubMedCentral Rosenstock S, Kay L, Rosenstock C, Andersen L, Bonnevie O, Jørgensen T: Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut. 1997, 41 (2): 169-76.CrossRefPubMedPubMedCentral
3.
go back to reference Talley N, Vakil N: Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005, 100 (10): 2324-37. 10.1111/j.1572-0241.2005.00225.x.CrossRefPubMed Talley N, Vakil N: Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005, 100 (10): 2324-37. 10.1111/j.1572-0241.2005.00225.x.CrossRefPubMed
4.
go back to reference Abahussain EA, Hasan FA, Nicholls PJ: Dyspepsia and Helicobacter pylori infection: Analysis of 200 Kuwaiti patients referred for endoscopy. Ann Saudi Med. 1998, 18 (6): 502-5.PubMed Abahussain EA, Hasan FA, Nicholls PJ: Dyspepsia and Helicobacter pylori infection: Analysis of 200 Kuwaiti patients referred for endoscopy. Ann Saudi Med. 1998, 18 (6): 502-5.PubMed
5.
go back to reference Henke CJ, Levin TR, Henning JM, Potter LP: Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am Gastroenterol. 2000, 95: 788-792. 10.1111/j.1572-0241.2000.01861.x.CrossRef Henke CJ, Levin TR, Henning JM, Potter LP: Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am Gastroenterol. 2000, 95: 788-792. 10.1111/j.1572-0241.2000.01861.x.CrossRef
6.
go back to reference Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S: Consumer usage patterns of nonprescription histamine2-receptor antagonists. Am J Gastroenterol. 2004, 99: 606-610. 10.1111/j.1572-0241.2004.04130.x.CrossRefPubMed Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S: Consumer usage patterns of nonprescription histamine2-receptor antagonists. Am J Gastroenterol. 2004, 99: 606-610. 10.1111/j.1572-0241.2004.04130.x.CrossRefPubMed
7.
go back to reference Talley NJ, Vakil NB, Moayyedi P: American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005, 129: 1756-1780. 10.1053/j.gastro.2005.09.020.CrossRefPubMed Talley NJ, Vakil NB, Moayyedi P: American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005, 129: 1756-1780. 10.1053/j.gastro.2005.09.020.CrossRefPubMed
8.
go back to reference Vakil N, Rhew D, Soll A, Ofman J: The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori. Am J Gastroenterol. 2000, 95: 1691-1698.PubMed Vakil N, Rhew D, Soll A, Ofman J: The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori. Am J Gastroenterol. 2000, 95: 1691-1698.PubMed
9.
go back to reference Talley NJ: Dyspepsia management in the millennium: the death of test and treat?. Gastroenterology. 2002, 122: 1521-1525. 10.1053/gast.2002.33370.CrossRefPubMed Talley NJ: Dyspepsia management in the millennium: the death of test and treat?. Gastroenterology. 2002, 122: 1521-1525. 10.1053/gast.2002.33370.CrossRefPubMed
10.
go back to reference Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G: Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000, 181: 1359-1363. 10.1086/315384.CrossRefPubMed Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G: Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000, 181: 1359-1363. 10.1086/315384.CrossRefPubMed
11.
go back to reference Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F, Miglioli M, Vaira D: Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol. 2004, 99: 823-829. 10.1111/j.1572-0241.2004.30162.x.CrossRefPubMed Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F, Miglioli M, Vaira D: Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol. 2004, 99: 823-829. 10.1111/j.1572-0241.2004.30162.x.CrossRefPubMed
12.
go back to reference Asfeldt AM, Straume B, Steigen SE, Løchen ML, Florholmen J, Bernersen B, et al: Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 2008, 23 (9): 625-33. 10.1007/s10654-008-9275-x.CrossRefPubMed Asfeldt AM, Straume B, Steigen SE, Løchen ML, Florholmen J, Bernersen B, et al: Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 2008, 23 (9): 625-33. 10.1007/s10654-008-9275-x.CrossRefPubMed
Metadata
Title
Prevalence of Helicobacter pyloriinfection among new outpatients with dyspepsia in Kuwait
Authors
Waleed M Alazmi
Iqbal Siddique
Nabeel Alateeqi
Basil Al-Nakib
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2010
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-10-14

Other articles of this Issue 1/2010

BMC Gastroenterology 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.